COMPANY PROFILE · UPDATED 18 NOV 2025

Pliant Therapeutics

Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or…

pliantrx.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2016
Headcount: 253
Open roles: 0
Last raised: Post Ipo Equity · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Roles at Pliant Therapeutics

Employbl doesn’t track Pliant Therapeutics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

FUNDING

Capital raised

Total raised

$694,945,152

Investors

Menlo VenturesAgent CapitalCOWENCormorant Asset ManagementEventideFarallon Capital ManagementLogos CapitalNovartisRedmile GroupS-Cubed CapitalSchroder AdveqSurveyor CapitalThird Rock VenturespH Pharma

Funding rounds

Post Ipo Equity
$287.5MJan 23, 2023
Post Ipo Equity
$200MJul 10, 2022
Series C
Novartis, Farallon Capital Management, Redmile Group, Surveyor Capital, Menlo Ventures, COWEN, S-Cubed Capital, Schroder Adveq, Eventide, Logos Capital, Cormorant Asset Management, Agent Capital
$100.4MMar 2, 2020
IPO
UndisclosedJan 1, 2020
Series B
COWEN, Eventide, Schroder Adveq, Agent Capital, Menlo Ventures, S-Cubed Capital
$62MJul 15, 2018
Series A
Third Rock Ventures, pH Pharma
$45MFeb 17, 2016

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Menlo Ventures

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

Mysql Php Vue.js Wordpress Java

LOCATIONS

Where they work

Pliant Therapeutics offices

Loading map…

South San Francisco, CA260 Littlefield Ave